MDK and melanoma: To this end, we generated subcutaneous xenografts of high‐MDK‐expressing melanoma cells: the murine B16R2L (Fig 6A–H) and the human SK‐Mel‐147 (Fig 6I–P) for analyses of drug response in immune‐competent and T‐cell‐deficient MetAlert mice, respectively.